Who founded Apervita?

Apervita was founded by Paul Magelli in 2012.

Who are Apervita's investors?

Apervita's investors include Bootstrap Venture Partners, Graphene Ventures.

How much funding has Apervita raised?

Apervita has disclosed $22.6M raised across 1 of its 3 known rounds.

Where is Apervita headquartered?

Apervita is headquartered in Chicago, US.

Apervita

Chicago, US · Founded 2012 · Delaware corporation · 2 known investors

Healthtech

Founders & leadership

Apervita was founded in 2012 by Paul Magelli.

Paul MagelliFounder

Blackford MiddletonExecutive

Michael LiangNamed on SEC filing

Michael OltmanNamed on SEC filing

Noah LewisNamed on SEC filing

Brad RyanNamed on SEC filing

David ShreinerNamed on SEC filing

David TuttleNamed on SEC filing

Geoff PhillipsNamed on SEC filing

Paul J MagelliNamed on SEC filing

Aaron SymanskiNamed on SEC filing

Board

Mark AchlerBoard director

Investors · 2

Bootstrap Venture PartnersSolana Beach

Graphene VenturesreportedPalo Alto · $500K – $2M

Reported raises · per SEC filings

Form D private placements

$22.6M disclosed across 1 of 3 rounds · 2014–2019

▶$22.6MraisedOct 2019 · 17 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

James BradleyDirector
Kevin HutchinsonExecutive Officer, Director
Mark AchlerDirector
Adam KoopersmithDirector
Michael LiangDirector
Kevin WeinsteinExecutive Officer
Kenneth JakobsenExecutive Officer
Blackford MiddletonExecutive Officer
Michael OltmanExecutive Officer
William McNallyExecutive Officer
Sarah LondonDirector

Offering amount: $22.6M
Amount sold: $22.6M
Minimum investment: $26.5K
First sale: Oct 2019
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$16.5MofferedAug 2017 · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Michael LiangDirector
Blackford MiddletonExecutive Officer
Michael OltmanExecutive Officer
Noah LewisDirector
Paul MagelliExecutive Officer, Director
Brad RyanExecutive Officer
David ShreinerExecutive Officer
David TuttleExecutive Officer

Offering amount: $16.5M
Minimum investment: $15K
Finders' fees: $520K
Placement agents: Manor Park Securities LLC
Incorporated: Corporation, Delaware, 2012
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$26MofferedDec 2014 · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Mark AchlerDirector
Geoff PhillipsExecutive Officer, Director, Promoter
Paul J MagelliExecutive Officer, Director, Promoter
Aaron SymanskiExecutive Officer

Offering amount: $26M
Minimum investment: $25K
Proceeds to insiders: $300B
First sale: Nov 2014
Incorporated: Corporation, Delaware, 2012
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Enhanced12 shared keywordsEnhanced offers clinician-prescribed peptides, prescriptions, and supplements sourced from licensed US pharmacies, with lab monitoring, delivered via a telehealth model. It targets consumers focused on physical performance and health optimization.

Companies competing with Apervita for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

Who founded Apervita?: Apervita was founded by Paul Magelli in 2012.
Who are Apervita's investors?: Apervita's investors include Bootstrap Venture Partners, Graphene Ventures.
How much funding has Apervita raised?: Apervita has disclosed $22.6M raised across 1 of its 3 known rounds.
Where is Apervita headquartered?: Apervita is headquartered in Chicago, US.